Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

MYLAN, LDA.

NIF 502248793
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €2,324,553 82 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €2,324,553 82 contracts
A2 · Late Publication €8,294,039,207 3,964 contracts
Contract published to BASE more than 10 days after the signing date
LOW €8,294,039,207 3,964 contracts
A5 · Threshold Splitting €54,757,596 123 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €54,757,596 123 contracts
A6 · Low Competition €50,460,981 23 contracts
Only one bidder participated in a competitive procedure
MEDIUM €50,460,981 23 contracts
A9 · Price Overrun €1,108 1 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €1,108 1 contracts
A9 · Abnormal Price Reduction €10,358,725,575 2,966 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €10,358,725,575 2,966 contracts
C3 · Missing Mandatory Fields €3,938,549 134 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €3,938,549 134 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

629
€589,858,012
210
€447,163,990
83
€441,720,723
82
€432,603,822
511
€423,531,450
173
€413,677,650
82
€397,743,265
367
€385,814,279
51
€354,752,201
71
€327,548,920
110
€306,836,004
136
€290,479,857
120
€276,174,798
314
€275,326,636
44
€274,584,628
51
€267,538,761
71
€263,643,601
67
€259,728,186
78
€256,883,015
158
€253,321,565
Page 1 of 4 · 69 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 1 · 1 contracts

Medicamentos
PT · df27db9b8642d26889e1 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Price Overrun
€1,107 2025-06-03
Overview
Total Value Won
€10,411,448,187
Contracts Won
5,679
Score 199820 · CRITICAL RISK
NIF
502248793
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.D. [P-98ca]
    Gerente
    since 2021-07-16
  • A.N. [P-80ea]
    Gerente
    since 2025-12-17
  • M.G. [P-8d91]
    Sócio
    since 2019-02-11
  • M.G. [P-f234]
    Sócio
    since 2009-06-19
  • A.Z. [P-7ca1]
    Gerente
    until 2013-08-27
  • A.Z. [P-7ca1]
    Gerente
    2016-03-17 → 2023-07-07
  • J.M. [P-3c82]
    Gerente
    until 2011-08-17
  • J.M. [P-f6b7]
    Gerente
    2011-08-17 → 2021-07-16
  • L.R. [P-b234]
    Gerente
    2023-07-07 → 2024-04-03
  • M.R. [P-c003]
    Gerente
    2024-04-08 → 2025-12-17
  • S.V. [P-457a]
    Gerente
    until 2016-03-17
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned